Plain-English translation of NCT07048496 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to deliver BCG therapy — an established immunotherapy treatment for early-stage bladder cancer — in the comfort of your own home instead of a hospital or clinic. The study also includes a digital conversational tool (like a text-based assistant) that helps you track your symptoms, monitor your quality of life, and stay motivated during treatment. Researchers hope this approach will make treatment easier and help more people complete their full course of therapy.
Many patients struggle to stay on track with bladder cancer treatment because frequent clinic visits are inconvenient and burdensome. This trial aims to find out what barriers and challenges prevent people from completing treatment, and whether receiving the medication at home with digital support can help patients stick with therapy and feel more in control.
You likely qualify if…
You likely don't qualify if…
If you're in the first part of the study, you'll be interviewed about your experiences with bladder cancer treatment and what makes it hard or easy to stick with. If you're in the second part, you'll receive BCG treatment at home using a catheter, and you'll use a mobile app or text-based conversational tool several times per week to check in about your symptoms, side effects, and how you're feeling. The study team will monitor your progress and provide support throughout your treatment.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States